Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

This study has been completed.
LG Life Sciences
Information provided by:
BioPartners GmbH Identifier:
First received: July 23, 2007
Last updated: January 15, 2008
Last verified: July 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given